Synopsys (SNPS) Tops Q3 EPS by 4c; Guides Q4 EPS Below Expectations
Get Alerts SNPS Hot Sheet
Price: $433.82 --0%
Revenue Growth %: +40.2%
Financial Fact:
Research and development: 221.95M
Today's EPS Names:
CCEL, FNGR, FAST, More
Revenue Growth %: +40.2%
Financial Fact:
Research and development: 221.95M
Today's EPS Names:
CCEL, FNGR, FAST, More
Join SI Premium – FREE
Synopsys (NASDAQ: SNPS) reported Q3 EPS of $0.63, $0.04 better than the analyst estimate of $0.59. Revenue for the quarter came in at $555.8 million versus the consensus estimate of $555.4 million.
Synopsys sees Q4 2015 EPS of $0.65-$0.67, versus the consensus of $0.70. Synopsys sees Q4 2015 revenue of $570-585 million, versus the consensus of $572.0 million.
Synopsys sees FY2015 EPS of $2.76-$2.78, versus the consensus of $2.78. Synopsys sees FY2015 revenue of $2.225-2.240 billion, versus the consensus of $2.23 billion.
For earnings history and earnings-related data on Synopsys (SNPS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AngioDynamics (ANGO) Tops Q4 EPS by 2c ; Offers Guidance
- Morgan Stanley Reiterates Overweight Rating on Befesa SA (BFSA:GR), sees a buying opportunity
- Bernstein SocGen Group Starts Asymchem Laboratories Tianjin Co Ltd (002821:CH) at Outperform
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share